import{d as u,o as g,g as b,c as s,b as h,e,F as l,f as c,j as v,w as f,k as y,n as d,t as o,l as _,i as r,_ as w}from"./index-AsVdvwHl.js";const S={class:"min-h-screen pt-24"},k={class:"px-6 py-20"},C={class:"mx-auto max-w-6xl"},P={class:"grid gap-8 lg:grid-cols-3"},z={class:"mb-4"},D={class:"mb-2 text-xl font-bold text-white"},N={class:"mb-2 text-sm text-slate-500"},q={class:"mb-6 text-slate-400"},B={class:"grid grid-cols-3 gap-4 border-t border-slate-800 pt-6"},T={class:"text-xs text-slate-500"},A={class:"bg-gradient-to-b from-[#020617] via-slate-900/30 to-[#020617] px-6 py-20"},V={class:"mx-auto max-w-6xl"},R={class:"grid gap-8 md:grid-cols-2"},E={class:"mb-6 text-lg text-slate-300"},I={class:"font-bold text-white"},O={class:"text-sm text-slate-500"},F={class:"px-6 py-20"},L={class:"mx-auto max-w-4xl text-center"},M={class:"flex flex-wrap justify-center gap-4"},j=u({__name:"CaseStudiesPage",setup(G){const p=[{id:1,title:"GLP-1 Agonist Optimization",partner:"Major Pharma Partner",category:"Peptide Therapeutics",description:"Optimized a novel GLP-1 receptor agonist for improved stability and reduced immunogenicity.",results:[{metric:"10x",label:"Faster Design Cycles"},{metric:"47%",label:"Improved Stability"},{metric:"3",label:"IND-Enabling Candidates"}],color:"cyan"},{id:2,title:"De Novo Protein Binder Design",partner:"Biotech Startup",category:"Protein Design",description:"Designed novel protein binders targeting an undruggable oncology target with high specificity.",results:[{metric:"1000+",label:"Candidates Evaluated"},{metric:"<10nM",label:"Binding Affinity"},{metric:"8 weeks",label:"To Lead Candidate"}],color:"purple"},{id:3,title:"mRNA Vaccine Optimization",partner:"Academic Institution",category:"mRNA Therapeutics",description:"Optimized mRNA constructs for a personalized neoantigen cancer vaccine with improved expression.",results:[{metric:"5x",label:"Expression Increase"},{metric:"94%",label:"Validation Rate"},{metric:"2x",label:"Half-life Extension"}],color:"pink"}],x=[{quote:"Sequentia's platform accelerated our peptide program by over a year. The quality of candidates exceeded our expectations.",author:"VP of Discovery",company:"Top 10 Pharma"},{quote:"The ability to specify our therapeutic goals in natural language and get optimized candidates back is transformative.",author:"CSO",company:"Clinical-Stage Biotech"}];return g(()=>{const i=document.querySelectorAll(".case-card");i.length>0&&b.fromTo(i,{opacity:0,y:30},{opacity:1,y:0,stagger:.15,duration:.6,ease:"power3.out",delay:.2})}),(i,a)=>{const m=y("router-link");return r(),s("div",S,[a[6]||(a[6]=h('<section class="px-6 py-20" data-v-f986e249><div class="mx-auto max-w-6xl" data-v-f986e249><span class="mb-4 inline-block rounded-full border border-amber-500/30 bg-amber-500/10 px-4 py-1 text-sm font-medium text-amber-300" data-v-f986e249> Case Studies </span><h1 class="mb-6 text-5xl font-bold text-white md:text-6xl" data-v-f986e249> Proven <span class="bg-gradient-to-r from-amber-400 to-orange-400 bg-clip-text text-transparent" data-v-f986e249>Results</span></h1><p class="max-w-3xl text-xl text-slate-400" data-v-f986e249> See how our partners are using Sequentia&#39;s platform to accelerate therapeutic discovery and development. </p></div></section>',1)),e("section",k,[e("div",C,[e("div",P,[(r(),s(l,null,c(p,t=>e("div",{key:t.id,class:"case-card group rounded-2xl border border-slate-800 bg-slate-900/50 p-8 transition-all hover:border-slate-700"},[e("div",z,[e("span",{class:d(["rounded-full px-3 py-1 text-xs font-medium ring-1",[t.color==="cyan"?"bg-cyan-500/10 text-cyan-400 ring-cyan-500/30":"",t.color==="purple"?"bg-purple-500/10 text-purple-400 ring-purple-500/30":"",t.color==="pink"?"bg-pink-500/10 text-pink-400 ring-pink-500/30":""]])},o(t.category),3)]),e("h3",D,o(t.title),1),e("p",N,o(t.partner),1),e("p",q,o(t.description),1),e("div",B,[(r(!0),s(l,null,c(t.results,n=>(r(),s("div",{key:n.label,class:"text-center"},[e("div",{class:d(["text-2xl font-bold",[t.color==="cyan"?"text-cyan-400":"",t.color==="purple"?"text-purple-400":"",t.color==="pink"?"text-pink-400":""]])},o(n.metric),3),e("div",T,o(n.label),1)]))),128))])])),64))])])]),e("section",A,[e("div",V,[a[1]||(a[1]=e("h2",{class:"mb-12 text-center text-3xl font-bold text-white"},"What Partners Say",-1)),e("div",R,[(r(),s(l,null,c(x,t=>e("div",{key:t.author,class:"case-card rounded-2xl border border-slate-800 bg-slate-900/50 p-8"},[a[0]||(a[0]=e("svg",{class:"mb-4 h-10 w-10 text-cyan-500/30",fill:"currentColor",viewBox:"0 0 24 24"},[e("path",{d:"M14.017 21v-7.391c0-5.704 3.731-9.57 8.983-10.609l.995 2.151c-2.432.917-3.995 3.638-3.995 5.849h4v10h-9.983zm-14.017 0v-7.391c0-5.704 3.748-9.57 9-10.609l.996 2.151c-2.433.917-3.996 3.638-3.996 5.849h3.983v10h-9.983z"})],-1)),e("p",E,o(t.quote),1),e("div",null,[e("p",I,o(t.author),1),e("p",O,o(t.company),1)])])),64))])])]),e("section",F,[e("div",L,[a[4]||(a[4]=e("h2",{class:"mb-6 text-3xl font-bold text-white"},"Ready to Start Your Success Story?",-1)),a[5]||(a[5]=e("p",{class:"mb-8 text-lg text-slate-400"}," Join leading pharmaceutical and biotech companies using Sequentia to accelerate therapeutic discovery. ",-1)),e("div",M,[v(m,{to:"/contact",class:"rounded-full bg-gradient-to-r from-cyan-500 to-purple-600 px-8 py-4 font-semibold text-white shadow-lg shadow-cyan-500/30 transition-all hover:shadow-cyan-500/50"},{default:f(()=>a[2]||(a[2]=[_(" Start a Partnership ",-1)])),_:1,__:[2]}),a[3]||(a[3]=e("button",{class:"rounded-full border border-slate-700 px-8 py-4 font-medium text-white transition-all hover:border-cyan-500/50 hover:bg-slate-800"}," Download Full Case Studies ",-1))])])])])}}}),H=w(j,[["__scopeId","data-v-f986e249"]]);export{H as default};
